文献速递新发突发、热带与寄生虫病

登革病毒与寨卡病毒的血清学交叉反应及其对小鼠致病性的影响

Dengue Virus and Zika Virus Serological Cross-reactivity and Their Impact on Pathogenesis in Mice.
PubMed 文献 · J Infect Dis · 2019-01-01

研究利用稳健的小鼠模型,检验被动免疫、序贯交叉感染或灭活病毒疫苗接种后的病理结局。登革病毒感染可被登革和寨卡免疫增强(通过抗体依赖性增强)或抑制;灭活寨卡疫苗加重登革病严重度但对寨卡感染高度保护;登革免疫后寨卡感染未见抗体依赖性增强,但灭活登革疫苗主要增强肠系膜淋巴结中的寨卡感染。

要点

  • 灭活寨卡疫苗对寨卡感染高度保护,但加重登革病严重度。
  • 登革和寨卡免疫可增强或抑制登革病毒感染。
  • 灭活登革疫苗主要增强肠系膜淋巴结中的寨卡感染。

核心结论

  • 数据呼吁在设计寨卡或登革疫苗时更加关注细节。

研究设计与样本

  • 研究使用稳健的小鼠模型,检验被动免疫、序贯交叉感染或灭活病毒疫苗接种后的病理结局。

主要发现

  • 登革病毒感染可被登革和寨卡免疫增强(通过抗体依赖性增强)或抑制。
  • 灭活寨卡疫苗接种对寨卡感染高度保护,但加重登革病严重度。
  • 被动免疫或预先感染登革的小鼠在寨卡感染时未观察到抗体依赖性增强。
  • 灭活登革疫苗接种主要增强肠系膜淋巴结中的寨卡感染,表明登革免疫在体内可能导致抗体依赖性增强。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Preexisting immunity to Zika virus (ZIKV) or dengue virus (DENV) may alter the course of their infection, and here we use robust mouse models to examine pathological outcomes following passive immunization, sequential cross-infection, or vaccination with inactivated virus. DENV infection was enhanced (through antibody-dependent enhancement [ADE]) or was suppressed by both DENV and ZIKV immunity. Notably, inactivated ZIKV vaccination enhanced dengue disease severity, although it was highly protective against ZIKV infection. On the other hand, ADE was not observed upon ZIKV infection in mice that were passively immunized or preinfected with DENV. Surprisingly, however, we found that vaccination with inactivated DENV enhanced ZIKV infection, mainly in the mesenteric lymph node, indicating the potential for DENV immunity to cause ADE in vivo. Collectively, our data call for greater attention to detail in the design of ZIKV or DENV vaccines.

来源:J Infect Dis,查看原文。版权归原作者所有。

引用

  1. Watanabe S, Tan NWW, Chan KWK, et al. Dengue Virus and Zika Virus Serological Cross-reactivity and Their Impact on Pathogenesis in Mice. J Infect Dis. 2019. PMID: 30085051. doi:10.1093/infdis/jiy482

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。